Found 19 matching trials
Glucose Reduction by Early Acarbose Treatment in Basal Insulin PHASE4 The purpose of this study is to evaluate the efficacy and safety of acarbos...
Show More Location
Multiple Locations
Learn More & Join Trial
Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis NA The purpose of this study is to determine whether adult DKA patients who pr...
Show More Location
University of Maryland Medical Center
Learn More & Join Trial
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis PHASE2 Diabetic ketoacidosis (DKA) is a medical emergency that is associated with ...
Show More Learn More & Join Trial
Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan NA To compare different timing of insulin Glargine administration (early-6 pm ...
Show More Learn More & Join Trial
Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study) PHASE3 Type 2 diabetes mellitus is a chronic metabolic disorder characterized by p...
Show More Location
Mount Sinai Hospital
Learn More & Join Trial
Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) PHASE3 Type 2 diabetes mellitus is a chronic metabolic disorder characterized by p...
Show More Location
Mount Sinai Hospital
Learn More & Join Trial
Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes PHASE4 A frequent complication in the management of diabetic ketoacidosis (DKA) in...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes PHASE4 The purpose of this study, which is being conducted at 100 centers througho...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM PHASE4 Type 2 diabetes is a systemic metabolic disease with significant morbidity ...
Show More Location
Texas Diabetes Institute
Learn More & Join Trial
A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study PHASE4 This study compares the effect on blood sugar levels of two medicines: insu...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial